What is Walvax Biotechnology Co Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Walvax Biotechnology Co's Average Total Inventories for the quarter that ended in Mar. 2024 was ¥1,068 Mil. Walvax Biotechnology Co's Revenue for the
three
months ended in Mar. 2024 was ¥600 Mil.
Walvax Biotechnology Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.78.
Walvax Biotechnology Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024
increased
from Dec. 2023 (1.11) to Dec. 2023 (1.78)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Walvax Biotechnology Co's Days Inventory for the
three
months ended in Mar. 2024 was 858.32.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Walvax Biotechnology Co's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.11.
Walvax Biotechnology Co Inventory-to-Revenue Historical Data
The historical data trend for Walvax Biotechnology Co's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Walvax Biotechnology Co Inventory-to-Revenue Chart
Competitive Comparison of Walvax Biotechnology Co's Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Walvax Biotechnology Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Walvax Biotechnology Co's Inventory-to-Revenue falls into.
Walvax Biotechnology Co Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Walvax Biotechnology Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Walvax Biotechnology Co (SZSE:300142) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Walvax Biotechnology Co's Days Inventory for the
three
months ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Walvax Biotechnology Co Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Walvax Biotechnology Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Walvax Biotechnology Co (SZSE:300142) Business Description
Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300142 has been successfully added to your 